financetom
Business
financetom
/
Business
/
Gogo Partners With Alamo Engineering to Develop European Supplemental Type Certificate for HDX Gogo Galileo System
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gogo Partners With Alamo Engineering to Develop European Supplemental Type Certificate for HDX Gogo Galileo System
May 28, 2024 1:13 AM

03:57 AM EDT, 05/28/2024 (MT Newswires) -- Gogo ( GOGO ) said Tuesday it has teamed up with Alamo Engineering to develop a European Supplemental Type Certificate for its business aviation internet system Gogo Galileo HDX for the Cessna Citation Latitude.

The planned certificate, which will be the fourth for HDX Gogo Galileo system, will cover nearly 400 aircraft worldwide, the company said.

Price: 10.40, Change: -0.04, Percent Change: -0.38

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Groupe Dynamite Q3 Adjusted Profit, Revenue Advance
Groupe Dynamite Q3 Adjusted Profit, Revenue Advance
Dec 17, 2024
07:35 AM EST, 12/17/2024 (MT Newswires) -- Groupe Dynamite ( GRGDF ) on Tuesday reported higher third-quarter adjusted profit and revenue that beat estimates. The company, which operates two women's clothing brands, said adjusted diluted net earnings increased to $43.7 million, or $0.41 per share, from $35.7 million, or $0.33 per share, last year. The result beat the consensus analyst...
Marimaca Copper Secures Option to Buy Madrugador Project in Chile
Marimaca Copper Secures Option to Buy Madrugador Project in Chile
Dec 17, 2024
07:32 AM EST, 12/17/2024 (MT Newswires) -- Marimaca Copper ( MARIF ) said Tuesday that it signed a binding option agreement to acquire the Madrugador project in Chile. The company said Madrugador is located near the Pampa Medina project, and the acquisition consolidated its ownership of the southern extent of the Sierra de Medina property package. Under the terms, Marimaca...
IDEAYA Biosciences Gets Move-Forward Dose for Phase 2/3 Darovasertib-Crizotinib Trial
IDEAYA Biosciences Gets Move-Forward Dose for Phase 2/3 Darovasertib-Crizotinib Trial
Dec 17, 2024
07:30 AM EST, 12/17/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Tuesday an independent data monitoring committee has recommended a move-forward dose for a potential registration-enabling phase 2/3 trial to evaluate the company's darovasertib combined with Pfizer's ( PFE ) crizotinib in patients with a certain metastatic uveal melanoma. Chief Medical Officer Darrin Beaupre said the committee's recommendation...
Teva, Sanofi say drug to treat IBD met primary targets
Teva, Sanofi say drug to treat IBD met primary targets
Dec 17, 2024
JERUSALEM, Dec 17 (Reuters) - Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and Crohn's disease showed it had met primary goals. Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping it will become a blockbuster drug - or one...
Copyright 2023-2026 - www.financetom.com All Rights Reserved